Long-acting Etonogestrel Microspheres

Description: Orbis Biosciences is developing a 6-month injectable microsphere formulation containing etonogestrel using Orbis Biosciences' patented Precision Particle Fabrication (PPF) technology for achieving uniform particle size.

Product Details

Delivery Method: ,

Duration: 6 months

Regimen:

Active Pharmaceutical Ingredient (API):

Status Details

Began discovery in: 2013

Additional Information

References:

Vertical Tabs

Print